AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Use of intradermal botulinum toxin to reduce sebum production and facial pore size.(ORIGINAL ARTICLES)(Report)

Journal of Drugs in Dermatology

| September 01, 2008 | Shah, Anil R. | COPYRIGHT 2009 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

ABSTRACT

Objective: Review the safety profile and subjective efficacy of intradermal botulinum toxin type A in facial pore size and sebum production.

Design: Retrospective analysis of 20 patients.

Results: Twenty consecutive patients with a single application of intradermal botulinum toxin type A were examined: Patients (17/20) noted an improvement in sebum production and a decrease in pores size at 1 month after injection. No complications were observed, and 17/20 patients were satisfied with the procedure.

Conclusion: Preliminary data suggests that intradermal botulinum toxin may play a role in decreasing sebum production. Further quantitive study may be necessary to determine effects of intradermal botulinum toxin on pore size.

INTRODUCTION

Facial pore size and excessive sebum production are notoriously difficult skin conditions to treat. Numerous techniques have been described with limited results or significant drawbacks. A variety of skin resurfacing modalities have been described, but results have been mixed and inconsistent. One potential reason for this limitation is that the location of the sebaceous gland is in the deeper portion of the dermis, a difficult area to reach by resurfacing modalities.

Deeper resurfacing techniques can lead to hyperpigmentation and hypopigmentation, especially in patients with Fitzpatrick skin type 4 and higher, long recovery periods, and permanent scarring. The mechanism of isotrentinoin (Accutane[R]), is currently unknown, but it theoretically decreases sebum production. (1) However, a main drawback of isotrentinoin therapy is serious systemic side effects, including liver dysfunction, mucosal bleeding, and cardiac disease. In addition, several studies have suggested a possible link between isotrentinoin and depression, suicide, anxiety, and aggressive behavior. (2-6)

The use of intradermal botulinum toxin type A (Botox[R]) remains a relatively new technique. At the time of publication, no reports were found in the literature that describe its effects on sebum production and pore size. The author first noticed the effects of botulinum toxin on the skin after an injection along the procerus to treat "bunny lines." Patients reported improvement in skin quality and less skin shininess. Further investigation lead to isolated reports from Southeast Asia of physicians using…

Related articles from newspapers, magazines, journals, and more
S Black has produced REGU[TM]-SEB, a new formulation designed to control and...
Magazine article from: Cosmetics International July 10, 2002 700+ words
S Black has produced REGU[TM]-SEB, a new formulation designed to control and reduce sebum production in skin that is prone to oiliness. The ingredient, which is manufactured by Pentapharm Limited, contains polyphenol-rich fractions...
Botulinum Toxin Type A (Parenteral-Local ).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language July 28, 2005 700+ words
...Neuromuscular blocking agent Description Botulinum toxin type A (BOT-yoo-lye-num) is...the eyes do not line up properly. Botulinum toxin type A is injected into the surrounding...than one treatment may be required. Botulinum toxin type A is also used to treat muscle...
Botulinum Toxin Type A (Parenteral-Local).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2006 700+ words
...Neuromuscular blocking agent Description Botulinum toxin type A (BOT-yoo-lye-num) is...the eyes do not line up properly. Botulinum toxin type A is injected into the surrounding...than one treatment may be required. Botulinum toxin type A is also used to treat muscle...
Botulinum toxin in otolaryngology: A review of its actions and opportunities...
Magazine article from: Ear, Nose and Throat Journal Neuenschwander, Michael C. Pribitkin, Edmund A. Sataloff, Robert T. October 1, 2000 700+ words
Abstract Botulinum toxin has several important properties...side effects and complications. Botulinum toxin is being used safely in a wide...lines. Studies have shown that botulinum toxin injections have a high rate of...
Analysis finds botulinum toxin type A is safe, well tolerated.
Newspaper article from: Biotech Business Week July 12, 2004 700+ words
...over the last 15 years shows that botulinum toxin type A (Botox) has a favorable safety...comprehensive review of the safety of botulinum toxin type A to date, were announced at...first time a comprehensive review of botulinum toxin type A studies has been undertaken...
Comprehensive Research Finds Botulinum Toxin Type A is Safe and Well Tolerated...
Press release article from: PR Newswire June 14, 2004 700+ words
...over the last 15 years shows that botulinum toxin type A (BOTOX(R)) has a favorable...comprehensive review of the safety of botulinum toxin type A to date, were announced at...first time a comprehensive review of botulinum toxin type A studies has been undertaken...
DOR BioPharma Initiates New Botulinum Toxin Therapeutic Program; Complements...
Press release article from: Business Wire February 16, 2005 700+ words
...molecule drugs to counter the deadly effects of Botulinum toxin exposure. Botulinum toxin is generally regarded as the most poisonous...that either slow or reverse the effects of Botulinum toxin. Capitalizing on research focused on structure...
The changed image of botulinum toxin: its unlicensed use is increasing...
Magazine article from: British Medical Journal Misra, V Peter November 23, 2002 700+ words
Over the past decade botulinum toxin has had a makeover. Earlier...fatal muscular paralysis. Today botulinum toxin is widely known as a pharmaceutical...new image as a glamour drug. Botulinum toxin is reported to be useful in...
Botulinum toxin type A (Parenteral-Local).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language January 1, 1997 700+ words
...and Canada is Botox. Description Botulinum toxin type A (BOT-yoo-lye-num) is...the eyes do not line up properly. Botulinum toxin type A is injected into the surrounding...you and your doctor will make. For botulinum toxin type A, the following should be considered...
Botulinum toxin type A in treatment of bilateral primary axillary...
Magazine article from: British Medical Journal Naumann, M Lowe, NJ September 15, 2001 700+ words
...evaluate the safety and efficacy of botulinum toxin type A in the treatment of bilateral...Interventions Patients received either botulinum toxin type A (Botox) 50 U per axilla or...At four weeks, 94% (227) of the botulinum toxin type A group had responded compared...
For more facts and information, see all results

Source: HighBeam Research, Use of intradermal botulinum toxin to reduce sebum production and...

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily